The global synthetic spider silk market size is expected to reach USD 1,486.5 Mn in 2026 and is anticipated to rise to USD 2,388.0 Mn by 2033, growing at a compound annual growth rate (CAGR) of 7.06% from 2026 to 2033. The growth can be attributed to the rising demand for high-quality and eco-friendly biomaterials used in the textile, medical, defense, and advanced engineering material sectors, among others, along with innovations in bioengineering and protein synthesis technologies.
Genetically Modified Yeast Fermentation is anticipated to capture the maximum market share among all synthetic spider silk product type market segments, contributing 45% to the market in 2026. This is due to its scalability, stable for protein expression and works well with existing bioreactors that are used for synthesizing spider silk proteins.
Fermentation technology using yeast as the microorganism has the ability to manufacture silk proteins in bulk in an economically feasible manner without having to face problems posed by culturing spiders. Industrial biotechnology finds yeast more favorable due to its benefits in genetic engineering.
In September 2024, AMSilk GmbH, in collaboration with 21st.BIO, announced a strategic partnership to scale up the industrial production of recombinant spider silk proteins using advanced fermentation-based biomanufacturing platforms, including genetically engineered yeast expression systems.

To learn more about this report, Request Free Sample
The Automotive sector is expected to account for around 40% of the total global consumption of synthetic spider silk by 2026, making it one of the main applications of artificial spider silk. This share is driven by the expanding usage of artificial spider silk in lightweight composite materials, airbags, seat coverings, and other safety systems.
Synthetic spider silk is highly attractive to the automotive industry due to its superior tensile strength, elasticity, and light weight, thus helping manufacturers make their vehicles more fuel-efficient and safer for passengers.
In October 2024, Spiber Inc. expanded production and commercialization of its Brewed Protein materials, which are engineered protein fibers including spider silk–inspired structures.
|
Current Event |
Description and its Impact |
|
Expansion of U.S. and EU Biotechnology Funding Programs (2025–2026) |
|
|
Rising Adoption of Sustainable Material Regulations in the EU (Green Deal Implementation 2026) |
|
Uncover macros and micros vetted on 75+ parameters: Get instant access to report

To learn more about this report, Request Free Sample
In 2026, Europe will continue to be an important regional market in the global synthetic spider silk market, with a market share of around 40%, due to well-established research and development facilities for biotechnology along with rising applications in the fields of medicine, aerospace, and defense. The growth of the region can be attributed to stringent regulations concerning sustainability and the widespread use of bio-based materials.
For example, according to the European Commission (Circular Economy Action Plan), the promotion of bio-based products as an alternative to petroleum-based material usage is actively promoted in Europe, thereby contributing to the increasing demand for biomaterials like artificial spider silk.
In January 2024, German biotechnology company AMSilk GmbH and Danish biotech firm 21st.BIO announced a strategic partnership to accelerate the industrial-scale production of recombinant spider silk proteins using precision fermentation technology, including engineered microbial (yeast-based) expression systems.
The North American region is anticipated to witness the highest growth in the global synthetic spider silk market in the year 2026 due to rapid developments in biotechnology, investments in synthetic biology, and rising usage in the biomedical, aerospace, and defense sectors.
The growth in the region is highly facilitated by increased research and development funding and commercialization activities in the United States, through organizations like the NSF in the country that are focusing on bio-based materials as well as manufacturing innovations. This is leading to the development of protein-based fiber innovations for use in medical applications and various other fields.
In April 2026, U.S.-based biotechnology company Kraig Biocraft Laboratories announced that it had successfully produced over 1.3 metric tons of recombinant spider silk cocoons in a single production cycle, marking a record-breaking 5× increase over its previous output.
The U.S. synthetic spider silk market is projected to see considerable growth in the coming years, owing to significant innovations in biotechnology, synthetic biology, and recombinant protein technology, as well as increased commercialization activities by local firms including Kraig Biocraft Laboratories and Bolt Threads.
One major growth driver is the growing expenditure on high-performance biomaterials for defense, medical, and aviation uses, wherein spider silk is considered for its unique properties including tensile strength and elasticity. The U.S. Department of Defense and various research institutes have begun to invest heavily in the development of innovative bio-based materials, reducing dependency on petroleum-based materials.
China is forecasted to be one of the largest markets with respect to synthetic spider silk growth, owing to fast-paced growth in the country’s biotech sector, a well-established textile industry, and supportive government policies regarding advanced material innovations.
One of the most important growth drivers is the increasing investments in industrial biotechnology and bio-manufacturing facilities, resulting in the mass production of recombinant proteins such as spider silk biomaterials. The strength of the textile and technical fibers industry in China will further increase the demand for these high-performance materials.
China’s Ministry of Industry and Information Technology (MIIT) has confirmed that biomanufacturing and synthetic biology are key parts of the country’s strategic emerging industries, included under the national future industries and innovation development framework (15th Five-Year Plan direction, 2026–2030). These policies aim to strengthen industrial biotechnology, advanced biomaterials, and bio-based.
Some of the major key players in Synthetic Spider Silk are Kraig Biocraft Laboratories, Spiber Inc., AMSilk, and Bolt Threads.
| Report Coverage | Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 1,486.5 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 7.06% | 2033 Value Projection: | USD 2,388.0 Mn |
| Geographies covered: |
|
||
| Segments covered: |
|
||
| Companies covered: |
Kraig Biocraft Laboratories, Spiber Inc., AMSilk, and Bolt Threads |
||
| Growth Drivers: |
|
||
| Restraints & Challenges: |
|
||
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
Share
Share
Vidyesh Swar is a seasoned Consultant with a diverse background in market research and business consulting. With over 6 years of experience, Vidyesh has established a strong reputation for his proficiency in market estimations, supplier landscape analysis, and market share assessments for tailored research solution. Using his deep industry knowledge and analytical skills, he provides valuable insights and strategic recommendations, enabling clients to make informed decisions and navigate complex business landscapes.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients